Effect of narrowband ultraviolet B therapy on serum vitamin D and cathelicidin (LL-37) in patients with chronic plaque psoriasis

Journal of Cutaneous Medicine and Surgery

Volumn 18, Issue 1, 2014, Pages 43-48

  Al Mutairi, Nawaf ^a   Shaaban, Dalia ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b TANTA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37;

ADULT; ARTICLE; BURN; CHRONIC PLAQUE PSORIASIS; CONTROLLED STUDY; ERYTHEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NARROWBAND ULTRAVIOLET B THERAPY; PHOTOTHERAPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSORIASIS VULGARIS; RADIATION EXPOSURE; RADIATION RESPONSE; ULTRAVIOLET B RADIATION; VITAMIN BLOOD LEVEL; YOUNG ADULT;

ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; ULTRAVIOLET THERAPY; VITAMIN D;

EID: 84892604815     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2013.13087     Document Type: Article

References (28)

1. Mrowietz U, Reich K. Psoriasis - new insights into pathogenesis and treatment. Dtsch Arztebl Int 2009;106: 11-9.
2. Buchau AS, Gallo RL. Innate immunity antimicrobial defense systems in psoriasis. Clin Dermatol 2007;25: 616-24, doi:10.1016/j.clindermatol.2007.08. 016. (Pubitemid 350087608)
3. Baumgarth N, Bevins CL. Autoimmune disease: skin deep but complex. Nature 2007;449: 551.
4. Morizane S, Gallo RL. Antimicrobial peptides in the pathogenesis of psoriasis. J Dermatol 2012;39: 225-30, doi:10.1111/j.1346-8138. 2011.01483.x.
5. Miller J, Gallo RL. Vitamin D and innate immunity. Dermatol Ther 2010;23: 13-22, doi:10.1111/j.1529-8019.2009.01287.x.
6. Peric M, Koglin S, Kim SM, et al. IL-17A enhances vitamin D3- induced expression of cathelicidin antimicrobial peptide in human keratinocytes. J Immunol 2008;181: 8504-12.
7. Al-Mutairi N, Farag A, Al-Mutairi A, Al-Shiltawy M. Comorbidities associated with psoriasis: an experience from the Middle East. J Dermatol 2010;37: 146-55, doi:10.1111/j.1346-8138.2009.00777.x.
8. Vähävihu K, Ala-Houhala M, Peric M, et al. Narrowband ultraviolet B treatment improves vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitis. Br J Dermatol 2010;163: 321-8, doi:10.1111/j.1365-2133.2010.09767.x.
9. TVIT-ELISA Cisbio Bioassay. Available at: http://www.ria-cis.com/sites/ default/files/ressources/02-GB-TVITD-ELISA-Mod01.pdf (accessed June 28, 2013).
10. Gisondi P, Rossini M, Di Casare A, et al. Vitamin D status in patients with chronic plaque psoriasis. Br J Dermatol 2012;166: 505-10, doi:10.1111/j.1365-2133.2011.10699.x.
11. Al-Mutairi N, El Eassa B, Nair V. Measurement of vitamin D and cathelicidin (LL-37) levels in patients of psoriasis with comorbidities. Indian J Dermatol Venereol Leprol 2013;79: 492-6, doi:10.4103/0378-6323.113077.
12. Schwalfenberg GK. A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol Nutr Food Res 2011;55: 96-108, doi:10.1002/mnfr.201000174.
13. Dombrowski Y, Schauber J. Cathelicidin LL-37: a defense molecule with a potential role in psoriasis pathogenesis. Exp Dermatol 2012; 21: 327-30, doi:10.1111/j.1600-0625.2012.01459.x.
14. Frohm M, Agerberth B, Ahangari G, et al. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 1997;272: 15258-63, doi:10.1074/jbc.272.24.15258. (Pubitemid 27255544)
15. Lande R, Gregorio J, Facchinetti V, et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007;449: 564-9, doi:10.1038/nature06116. (Pubitemid 47525141)
16. Hänsel A, Günther C, Ingwersen J, et al. Human slan (6- sulfoLacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17/TH1 T-cell responses. J Allergy Clin Immunol 2011;127: 787-94, doi:10.1016/j.jaci.2010.12.009.
17. Ganguly D, Chamilos G, Lande R, et al. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med 2009;206: 1983-94, doi:10.1084/jem.20090480.
18. Wang TT, Nestel FP, Bourdeau V, et al. Cutting edge 1,25- dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004;173: 2909-12. (Pubitemid 39141992)
19. Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol 2010;62: 114-35, doi:10.1016/j.jaad.2009.08.026.
20. Peric M, Koglin S, Dombrowski Y, et al. Vitamin D analogs differentially control antimicrobial peptide/''alarmin'' expression in psoriasis. PLoS One 2009;4:e6340, doi:10.1371/journal.pone. 0006340.
21. Heilborn JD, Weber G, Grönberg A, et al. Topical treatment with the vitamin D analogue calcipotriol enhances the upregulation of the antimicrobial protein hCAP18/LL-37 during wounding in human skin in vivo. Exp Dermatol 2010;19: 332-8, doi:10.1111/j.1600-0625.2009.00997.x.
22. Gambichler T, Bechara FG, Scola N, et al. Serum levels of antimicrobial peptides and proteins do not correlate with psoriasis severity and are increased after treatment with fumaric acid esters. Arch Dermatol Res 2012;304: 471-4, doi:10.1007/s00403-012-1227-3.
23. Dombrowski Y, Peric M, Koglin S, et al. Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions. Sci Transl Med 2011;3: 82ra38, doi:10.1126/scitranslmed.3002001.
24. Fernandes-Alnemri T, Yu JW, Datta P, et al. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009;458: 509-13, doi:10.1038/nature07710.
25. Hornung V, Ablasser A, Charrel-Dennis M, et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009;458: 514-8, doi:10.1038/nature07725.
26. Dombrowski Y, Peric M, Koglin S, et al. Control of cutaneous antimicrobial peptides by vitamin D3. Arch Dermatol Res 2010; 302: 401-8, doi:10.1007/s00403-010-1045-4.
27. Sunil D, Dipankar DE. Narrowband ultraviolet B in the treatment of psoriasis: the journey so far! Indian J Dermatol Venereol 2010; 76: 652-61, doi:10.4103/0378-6323.72461.
28. Piskin G, Tursen U, Sylva-Steenland RM, et al. Clinical improvement in chronic-plaque type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-gamma inducers - IL-12, IL-18, and IL-23. Exp Dermatol 2004;13: 764-72, doi:10.1111/j.0906-6705.2004. 00246.x. (Pubitemid 39625223)